z-logo
open-access-imgOpen Access
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
Author(s) -
Daniel L. Hertz,
S. Roy,
Alison A. MotsingerReif,
A. Drobish,
L. S. Clark,
Howard L. McLeod,
L. A. Carey,
E. C. Dees
Publication year - 2013
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q1m1-ke46
Subject(s) - paclitaxel , medicine , breast cancer , oncology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom